Effect of PPARγ agonist (rosiglitazone) on the secretion of Th2 cytokine in asthma mice

Rosiglitazone can regulate the proportion of Treg and Th17 cells and inhibit the secretion of Th2 cytokines, which inhibit the airway inflammatory response for asthma mice effectively.